Aleksandra's project is focused on the development of iPSC-derived liver organoids - based “off-the-shelf” product for the disease modelling and drug discovery studies. The product will consist of hiPSCs-derived hepatocytes-like cells with liver metabolic zones-specific functionalities, and can be used as an alternative for primary human hepatocytesThe project is focused on the development of iPSC-derived liver organoids - based “off-the-shelf” product for the disease modelling and drug discovery studies. The product will consist of hiPSCs-derived hepatocytes-like cells with liver metabolic zones-specific functionalities, and can be used as an alternative for primary human hepatocytes.
Aleksandra Aizenshtadt recieves Growth House funding.
HTH researcher Aleksandra Aizenshtadt receives 50 000 NOK from The UiO Life Science Growth House in their first call for innovative researchers. Therese Bang received 10 000 NOK for her student project.
Published June 23, 2022 1:53 PM
- Last modified Nov. 11, 2022 4:38 PM